Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Obesity

glucose, (beta-d)-isomer has been researched along with Obesity in 145 studies

Research

Studies (145)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.69)	18.2507
2000's	12 (8.28)	29.6817
2010's	87 (60.00)	24.3611
2020's	45 (31.03)	2.80

Authors

Authors	Studies
Alheiros-Lira, MC; da-Silva, AC; da-Silva, HT; Ferraz, JC; Ferreira E Silva, WT; Jurema-Santos, GC; Leandro, CG; Moreno Senna, S	1
Fantuzzi, G; Pini, M	1
Galgani, M; Matarese, G	1
Abberton, KM; Hemmrich, K; Morrison, WA; Penington, AJ; Rophael, JA; Thomas, GP; Thompson, EW	1
Chan, L; Fantuzzi, G; Gove, ME; Pini, M; Sennello, JA; van Baal, JW	1
Bai, L; Ding, Y; Fan, Y; Fatima, M; Gao, J; Han, T; Wang, C; Zhang, Y	1
Fujimura, Y; Haseda, A; Hattori, H; Kondo, S; Kumazoe, M; Nakasone, A; Nishihira, J; Shimamoto, Y; Tachibana, H; Yamamoto, M; Yonekura, M; Yoshitomi, R	1
Anker, SD; Butler, J; Sattar, N; Verma, S	1
Acuna-Castillo, C; Aranda, M; Bustos, C; Calfío, C; Cubillos, FA; Del Campo, A; Díaz-Castro, F; Fajardo, A; Milla, LA; Pastene-Navarrete, ER; Rojo, LE; Salamanca, C; Troncoso, R; Villarroel, CA	1
Akour, A; Al-Tammemi, AB; AlMuhaissen, SA; Alrawashdeh, MN; An, H; Anastasia, L; Apkon, S; Armstrong, WS; Ayala Izurieta, JE; Barnett, K; Bhowmick, S; Biniskos, N; Booka, E; Brown, JC; Buchanan, SW; Campbell, C; Camporeale, A; Cantos, VD; Cao, Z; Chakraborty, RD; Chaturvedi, V; Chen, C; Chen, G; Chen, Y; Chou, PT; Ciconte, G; Colasanti, JA; Collins, LF; Darras, BT; de Carvalho, RM; De Morais, DC; Delegido, J; Dodd, J; Doki, Y; Dunfield, K; Elfring, G; Feng, B; Ferry, VE; Galaviz, KI; García, VJ; Greven, M; Guo, J; Gutierrez, M; Hameed, S; Hippler, M; Huang, JW; Isaac, ME; Ishihara, R; Ishikawa, H; Ito, Y; Jacobson, A; Jalouqa, S; James, TD; Jara Santillán, CA; Jiang, K; Jordan, R; Kampf, JW; Kato, H; Kato, K; Katzmarzyk, PT; Kaviani, A; Kawachi, H; Kawakubo, H; Khansari Nejad, N; Kitagawa, Y; Kojima, T; Kono, K; Koplowitz, B; Kubo, Y; Kuribayashi, S; Lahiri, CD; Lei, H; Leighton, C; Li, J; Liu, G; Lombardi, M; Lu, Y; Luo, Y; Ma, P; Mafa-Attoye, T; Mahmoud, NN; Makhlina, M; Makino, T; Manguso, F; Mano, M; Manso, AP; Marconi, VC; Márquez, CO; Matsubara, H; Matsuda, S; McDonald, CM; Mecarocci, V; Metcalfe, GD; Micaglio, E; Miele, L; Mire, EF; Miyazaki, T; Moi, CT; Moore, CM; Moran, CA; Muto, M; Nemoto, K; Nguyen, ML; Nusair, MB; Ochoa, A; Owen, G; Oyama, T; Palma-Dibb, RG; Pappone, C; Parsons, JA; Pasqualotto, N; Peltz, SW; Pesco Koplowitz, L; Pica, S; Postiglione, WM; Qureshi, M; Rhodes, J; Saeki, H; Sakai, M; Santinelli, V; Santos, C; Shah, NS; Shanahan, JP; Shieh, PB; Sisti, JM; Smith, TW; Sohda, M; Song, Y; Spana, C; Sturla, F; Su, BK; Sumitani, J; Szabo, B; Szymczak, NK; Tabiś, W; Takeuchi, H; Tang, X; Thevathasan, NV; Toh, Y; Tondi, L; Trifillis, P; Tsushima, T; Van Wittenberghe, S; Vicedomini, G; Wang, H; Wang, K; Wang, S; Wang, W; Wang, X; Wang, Y; Wu, F; Wu, X; Yamaji, T; Yamamoto, K; Yamatsuji, T; Yang, L; Yang, S; Yang, WH; Yang, Y; Yoshida, M; Yu, B; Yuan, L; Zabaleta, J; Zhang, C; Zhang, H; Zhang, L; Zhang, X; Zhang, Z; Zheng, WQ; Zheng, YX; Zhou, H; Zhou, J; Zhou, N; Zhu, W	1
Haluzik, M; Hüttl, M; Malinska, H; Markova, I; Miklankova, D; Poruba, M; Vaněčkova, I; Zapletalova, I	1
Barreto, J; Bonilha, I; Breder, I; Cintra, RM; Coelho-Filho, OR; Cunha, JS; de Carvalho, LSF; Guerra-Junior, G; Kimura-Medorima, ST; Munhoz, DB; Muscelli, E; Nadruz, W; Quinaglia, T; Soares, AAS; Sposito, AC; Wolf, VLW	1
Khan, MI; Khan, MZ; Kim, JD; Kim, MY; Lee, YB; Shin, JH; Shin, TS	1
Barkhof, F; IJzerman, RG; Kramer, MHH; Nieuwdorp, M; Schrantee, A; van Bloemendaal, L; van Ruiten, CC; Veltman, DJ	1
Huang, WJ; Liang, G; Lin, K; Luo, W; Qian, JF; Shan, PR; Xu, DY; Yang, N; Ye, SJ; Yuan, CX; Zhu, WW	1
Ferrante, C; Georgiev, MI; Marchev, AS; Mladenova, SG; Orlando, G; Savova, MS; Wabitsch, M	1
Bodicoat, DH; Chatterjee, S; Davies, MJ; Edwardson, CL; Gray, LJ; Khunti, K; King, JA; Poulin, B; Redman, EL; Sargeant, JA; Stensel, DJ; Waheed, G; Waller, HL; Webb, DR; Wilding, JPH; Willis, SA; Yates, T	1
IJzerman, RG; Kramer, MHH; Nieuwdorp, M; Ten Kulve, JS; van Ruiten, CC; Veltman, DJ; Wijdeveld, M	1
Dai, W; Peng, Q	1
Chen, C; Chen, X; Cowley, M; Cui, L; Geng, F; Huang, L; Huang, Z; Roelfsema, F; Tan, C; Wang, W; Wu, M	1
Albanese, C; Choos, END; Ecelbarger, CM; Jones, BA; Knoer, G; Kurtz, R; Lee, Y; Levi, M; Libby, A; Lo Cascio, JN; McCormack, M; Myakala, K; Nguyen, G; Ranjit, S; Rodriguez, O; Rosenberg, AZ; Shepard, BD; Wang, X	1
Chen, S; Luo, J; Piao, C; Wang, L; Zhao, X	1
Chen, B; Han, F; Kan, C; Kuang, Z; Ma, Y; Shi, J; Sun, X; Wu, D; Xu, Q; Ye, T; Zhang, J	1
Almengló, C; Durán, D; Eiras, S; Fernández, ÁL; Flores-Arias, MT; Fu, X; González-Juanatey, JR; Martínez-Cereijo, JM; Rodríguez-Mañero, M; Viñuela, JE	1
Ban, J; Chen, S; Chen, X; Jia, Z; Li, Z; Niu, S; Pan, X; Ren, Q; Yue, L; Zhen, R; Zhu, R	1
Adams, V; Augstein, A; Barthel, P; Goto, K; Jannasch, A; Labeit, S; Langner, E; Linke, A; Mangner, N; Männel, A; Schauer, A; Winzer, EB	1
Iji, M; Miura, Y; Miyaue, T; Takei, Y; Takemoto, K; Tanaka, M; Watanabe, C; Watanabe, H; Yamada, K; Yamane, Y	1
Ibuka, T; Kato, J; Kubota, M; Mizutani, T; Ohnishi, M; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T	1
Han, H; Kim, SR; Lee, JH; Oh, EY; Park, HJ; Park, JW; Park, KH	1
Chen, G; Kaneko, S; Nagashimada, M; Nagata, N; Ni, Y; Ota, T; Sakai, Y; Xu, L; Zhuge, F	1
Chatsudthipong, V; Jaikumkao, K; Lungkaphin, A; Pongchaidecha, A; Swe, MT; Thongnak, L	2
Choi, SH; Jang, HC; Lee, YK; Lim, HL; Oh, HN; Oh, TJ; Park, KS; Sul, WJ	1
Chen, C; Chen, Y; Cowley, MA; Huang, L; Huang, Z; Qi, X; Veldhuis, JD; Wang, C; Zhang, Y; Zhu, S	1
Abuaysheh, S; Batra, M; Chaudhuri, A; Dandona, P; Ghanim, H; Green, K; Hejna, J; Makdissi, A	1
Auger, C; Benrahla, D; Bruckert, C; Farooq, MA; Gaertner, S; Lee, HH; Lessinger, JM; Mayoux, E; Morel, O; Ohlmann, P; Park, SH; Pollet, B; Qureshi, AW; Schini-Kerth, VB; Stephan, D	1
Fan, L; Jiang, M; Li, L; Li, Y; Qu, X; Su, J	1
Chopey, IV; Debreceni, KO; Feysa, SV; Griadil, TI; Hechko, MM; Mykhalko, YO	1
Moorthy, M; Palanisamy, UD; Perera, A; Ton, SH	1
Dias, DA; Gill, H; Hung, A; Lenon, GB; Li, M; Luo, S; Nguyen, LT	1
Gra-Menendez, S; Iacobellis, G	1
Ayers, CR; de Albuquerque Rocha, N; Hughes, C; Jin, ES; Malloy, CR; Neeland, IJ	1
Amadid, H; Blond, MB; Bruhn, L; Clemmensen, KKB; Dejgaard, TF; Færch, K; Jørgensen, ME; Karstoft, K; Pedersen, C; Persson, F; Ried-Larsen, M; Tvermosegaard, M; Vainø, CTR; Vistisen, D	1
Fukuda, S; Ishii, Y; Kemmochi, Y; Kuroki, F; Miyajima, K; Nakae, D; Ohta, T; Sano, R; Sasase, T; Sugimoto, M; Yamanaka, M; Yasui, Y	1
Aly, A; Davey, M; Elbeddini, A; Erickson, D; Gallinger, J; Hooda, N; Lee, S; Tayefehchamani, Y	1
Htun, KT; Intachai, N; Jaikumkao, K; Kothan, S; Lungkaphin, A; Promsan, S; Swe, MT; Tapanya, M; Thongnak, L	1
Kurokawa, M; Sugita, C; Tsuhako, R; Yoshida, H	1
Hossin, AY; Inafuku, M; Nugara, RN; Oku, H; Takara, K	1
Enomoto, A; Fujishiro, M; Ishigami, M; Ito, A; Itoh, M; Ochi, K; Ogawa, Y; Ogi, T; Ono, K; Sawada, M; Shiraki, Y; Suganami, T; Tanaka, M; Watanabe, A; Yoshioka, N	1
Bellanger, D; Chappell, N; Elkind-Hirsch, KE; Seidemann, E; Storment, J	1
Belosludtsev, KN; Belosludtsev, MN; Belosludtseva, NV; Dubinin, MV; Mikheeva, IB; Starinets, VS	1
An, HJ; Jin, BR; Lee, M	1
Carbone, S; daSilva-deAbreu, A; Lavie, CJ	1
Bhatt, DL; Cahn, A; Diaz, R; Gause-Nilsson, IAM; Goudev, A; Kuder, J; Leiter, LA; McGuire, DK; Mosenzon, O; Murphy, SA; Oyama, K; Park, KS; Raz, I; Sabatine, MS; Špinar, J; Wilding, JPH; Wiviott, SD	1
Eriksson, JW; Johnsson, E; Katsogiannos, P; Lundkvist, P; Pereira, MJ; Sjöström, CD	1
Kajiya, S; Kawasoe, M; Kawasoe, S; Kubozono, T; Maruguchi, Y; Miyata, M; Ohishi, M; Uenomachi, H	1
Chen, G; Kaneko, S; Mayoux, E; Nagashimada, M; Nagata, N; Ni, Y; Ota, T; Xu, L; Zhuge, F	1
Amadid, H; Færch, K; Jørgensen, ME; Karstoft, K; Nielsen, LB; Persson, F; Ried-Larsen, M	1
Choi, JW; Kim, SL; Lee, CW; Lee, J; Park, YI; Seo, JY	1
Fukagawa, M; Miyauchi, M; Toyoda, M	1
Guo, J; Guo, Y; Han, X; Huang, W; Huang, Y; Jin, W; Liang, C; Liu, G; Liu, X; Ma, T; Meng, M; Ren, C; Sun, X; You, Y; Yuan, X; Zhan, J; Zhang, Q	1
Ishii, S; Koiwai, K; Mitsuyoshi, R; Okamura, T; Pfarr, E; Shiba, T	1
Ishii, S; Kato, H; Nagai, Y; Nakagawa, T; Nakamura, Y; Ohta, A; Sasaki, Y; Tanaka, Y	1
Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Kerdphoo, S; Pratchayasakul, W; Sa-Nguanmoo, P; Tanajak, P	1
Imamura, M; Kurosaki, E; Tahara, A; Takasu, T; Yokono, M	1
Jin, JS; Jung, Y; Kang, J; Kim, HL; Kwak, HJ; Lim, S; Park, H; Park, J; Song, G; Um, JY; Youn, DH	1
Levi, M; Luo, Y; Myakala, K; Orlicky, DJ; Wang, D; Wang, X; Yang, P	1
Bhatt, DL; Bonaca, MP; Cahn, A; Gause-Nilsson, IAM; Johansson, PA; Kato, ET; Langkilde, AM; Leiter, LA; McGuire, DK; Mosenzon, O; Raz, I; Sabatine, MS; Silverman, MG; Wilding, JPH; Wiviott, SD	1
Tian, L; Wu, S	1
Kitzman, DW; Packer, M	1
Chatsudthipong, V; Chattipakorn, N; Chueakula, N; Jaikumkao, K; Lungkaphin, A; Pongchaidecha, A; Thongnak, L; Wanchai, K	1
Abbate, A; Billingsley, HE; Buckley, LF; Buzzetti, R; Canada, JM; Carbone, S; Christopher, S; Dixon, DL; Kadariya, D; Markley, R; Medina de Chazal, H; Trankle, CR; Van Tassell, BW; Vo, C	1
Takakura, S; Takasu, T	1
Castilho, PC; Spínola, V	1
Cao, M; Li, Y; Qin, Y; Wang, T; Xu, Y; Zhai, Q; Zhao, K	1
Furukawa, E; Furukawa, S; Hiasa, Y; Matsuura, B; Miyake, T; Niiya, T; Sakai, T; Senba, H; Yamamoto, S	1
Abdurrachim, D; Chan, WX; Lalic, J; Lam, CSP; Lee, PTH; Teo, XQ; Woo, CC	1
Baek, J; Brailsford, AD; Buddeberg, BS; Cho, BK; Cho, MJ; Choi, DH; Choi, K; Choi, YH; Cowan, DA; Gordon, IL; Hamblin, MR; Jang, JH; Kaelin Agten, A; Khalil, A; Kim, HJ; Kim, JH; Kim, KH; Kim, SI; Kim, SK; Kim, SW; Ko, JS; Koga, S; Lavery, LA; Lee, JH; Lee, JY; Li, H; Li, K; Liu, C; Liu, Q; Luo, X; Ma, MH; Majidin, WNM; Nong, F; O'Driscoll, JM; Osawa, M; Park, GE; Park, J; Park, SH; Pei, M; Phi, JH; Sakaue, H; Sengoku, Y; Sharma, R; Son, Y; Takagi, H; Thein, MS; Thilaganathan, B; Wakabayashi, H; Walker, C; Washington, K; Wason, J; Wen, B; Wojek, N; Yang, H; Zhao, Z; Zhou, L	1
Arvapalli, R; Bandarupalli, VVK; Blough, ER; Ginjupalli, GK; Graffeo, VA; Manne, NDPK; Rice, KM	1
Endo, J; Inoue, K; Katsumata, Y; Sano, M; Shirakawa, K; Yano, W	1
Castilho, PC; Llorent-Martínez, EJ; Spínola, V	1
Azuma, M; Dat Le, T; Hiraki, N; Inoue, YH; Omura, F; Yamanaka, M; Yoshimoto, Y	1
Abbas, J; Atkin, SL; Deshmukh, H; Javed, Z; Khan, AY; Kilpatrick, ES; Papageorgiou, M; Qamar, U; Rigby, AS; Sathyapalan, T	1
Han, YH; Hong, SH; Jeon, HD; Kee, JY; Liu, XQ; Mun, JG; Park, J; Park, SH; Zou, QP	1
Kitamura, K; Miyachi, Y; Mori, K; Nakamura, S; Ogawa, Y; Shiba, K; Tsuchiya, K	1
Ito, K; Kashiwagi, Y; Kimura, H; Nagoshi, T; Oi, Y; Tanaka, TD; Tanaka, Y; Yoshii, A; Yoshimura, M; Yoshino, T	1
Hayashizaki, Y; Imamura, M; Kihara, R; Kobayashi, Y; Kurosaki, E; Li, Q; Noda, A; Sasamata, M; Shibasaki, M; Tahara, A; Takasu, T; Tomiyama, H; Yamajuku, D; Yokono, M	1
Bello, NT; Verpeut, JL; Walters, AL	1
Chellan, N; Fey, SJ; Ghoor, S; Joubert, E; Louw, J; Muller, CJ; Pheiffer, C; Sanderson, M	1
Chi, R; Kong, P; Lu, Y; Wang, N; Zhang, L	1
Jeong, EJ; Kang, J; Kim, HP; Kim, YC; Lee, M; Lee, SH; Sung, SH; Yang, H	1
Akhtar, N	1
Bays, HE; Canovatchel, W; Law, G; Weinstein, R	1
García, SD; Sanz, AD; Sanz, SD	1
Hayashizaki, Y; Kihara, R; Kurosaki, E; Li, Q; Mitsuoka, K; Miyoshi, S; Muramatsu, Y; Sasamata, M; Shibasaki, M; Tahara, A; Takasu, T; Tomiyama, H; Uchiyama, Y; Yokono, M	1
Condren, AB; Donahue, EP; Farmer, TD; Healey, EC; Kim, K; McCoy, GA; O'Brien, TP; Printz, RL; Shiota, M; Ueta, K	1
Ma, LY; Wu, XY; Yu, RQ; Zhou, X; Zhu, J	1
Broedl, UC; Frappin, G; Jelaska, A; Kim, G; Rosenstock, J; Salsali, A; Woerle, HJ	1
Bartaun, C; Gembardt, F; Hohenstein, B; Hugo, C; Jarzebska, N; Mayoux, E; Todorov, VT	1
Guo, Y; Kong, P; Lin, D; Lu, Y; Zhang, L	1
Bouwens, L; Chellan, N; Cnop, M; Da Cunha, DA; Himpe, E; Joubert, E; Ladriere, L; Louw, J; Mathijs, I; Muller, C; Roux, CR	1
Beckers, J; Hrabé de Angelis, M; Huypens, P; Neschen, S; Rathkolb, B; Scheerer, M; Schultheiss, J; Seelig, A; Suhre, K; Wolf, E; Wu, M; Wurst, W	1
Hasegawa, Y; Kim-Mitsuyama, S; Koibuchi, N; Kusaka, H; Lin, B; Ma, M; Nakagawa, T; Sueta, D; Toyama, K; Uekawa, K	1
Murosaki, S; Muroyama, K; Ohara, T; Yamamoto, Y	2
Camps, J; García-Heredia, A; Geeraert, B; Holvoet, P; Joven, J; López-Sanromà, S; Rull, A	1
Yang, B; Yu, B; Zhang, L	1
Pickl, S	1
Bagger, JI; Knop, FK; Rungby, J; Storgaard, H; Vilsbøll, T	1
Dixon, JB	1
Fujita, K; Honda, Y; Imajo, K; Kato, S; Kato, T; Kessoku, T; Mawatari, H; Nakajima, A; Ogawa, Y; Saito, S; Tomeno, W; Yoneda, M	1
Adkins, YC; Bonnel, EL; Breksa, AP; Freytag, TL; Kelley, DS; Mackey, BE; Manners, GD; Storms, DH; Woodhouse, LR; Zunino, SJ	1
Fujisawa, Y; Kittikulsuth, W; Kohno, M; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Ogata, H; Ohmori, K; Rahman, A; Takeshige, Y	1
Demirci-Tansel, C; Gurel-Gurevin, E; Mericli, F; Ustunova, S; Yazici-Tutunis, S	1
Broedl, UC; Chilton, R; Crowe, S; Johansen, OE; Lund, SS; McGuire, DK; Neeland, IJ; Woerle, HJ	1
Furuke, S; Kanno, K; Komiya, C; Miyachi, Y; Ogawa, Y; Shiba, K; Shimazu, N; Tsuchiya, K; Yamaguchi, S	1
Aihara, Y; Asada, K; Douhara, A; Kawaratani, H; Kitade, M; Moriya, K; Namisaki, T; Nishimura, N; Noguchi, R; Okura, Y; Takeda, K; Yoshiji, H	1
Atsumi, T; Ichiyama, M; Kameda, R; Miyoshi, H; Nakamura, A; Nomoto, H; Ono, K; Sugawara, H; Yamamoto, C; Yamamoto, K	1
Gupta, Y; Kalra, S; Kishor, K	1
Guo, S; Jiang, K; Liu, X; Luo, L; Shen, N; Sun, C; Wang, C; Wang, M; Xu, M; Yang, Y; Yao, L	1
Chellan, N; Joubert, E; Malherbe, CJ; Miura, Y; Muller, CJF; Yagasaki, K	1
Abiko, A; Atageldiyeva, K; Fujita, Y; Haneda, M; Honjo, J; Makino, Y; Mizumoto, K; Takeda, Y; Takiyama, Y; Yanagimachi, T	1
Ishibashi, Y; Matsui, T; Yamagishi, SI	1
Benetti, E; Chiazza, F; Collino, M; Cutrin, JC; Fantozzi, R; Mastrocola, R; Mayoux, E; Nigro, D; Vitarelli, G	1
Amini, S; Eriksson, JW; Johnsson, E; Lundkvist, P; Pereira, MJ; Sjöström, CD	1
Aronne, LJ; Mauer, EA; Rathi, S; Shukla, AP; Thomas, CE	1
Fujimori, Y; Isaji, M; Ishikawa-Takemura, Y; Katsuno, K	1
Benhabilès, N; Crombé, F; Geeraert, B; Geuns, JM; Holvoet, P; Hulsmans, M	1
Berniakovich, I; Giorgio, M; Minucci, S; Pelicci, PG; Petroni, K; Porrini, M; Rapisarda, P; Reforgiato Recupero, G; Riso, P; Stendardo, M; Titta, L; Tonelli, C; Trinei, M	1
Dobbins, RL; Hussey, EK; Kapur, A; Layko, D; Murray, SC; Nunez, DJ; O'Connor-Semmes, RL; Stockman, NL; Stoltz, RR	1
Jones, HB; Macdonald, FR; Mayers, RM; Peel, JE; Poucher, SM; Westgate, L; Whaley, JM	1
Li, D; Li, G; Ling, W; Wang, D; Wei, X; Xia, M; Xiao, Y; Yang, Y; Zhu, Y	1
Correia, JF; de Oliveira, LF; Ferreira, EA; Filho, DW; Gris, EF; Pedrosa, RC; Rebello, JM	1
Guo, H; Ling, W; Xia, M; Zhang, W; Zhong, R; Zou, T	1
Cullen, MJ; Devenny, JJ; Godonis, HE; Harvey, SJ; Pelleymounter, MA; Rooney, S	1
Aoki, H; Horio, F; Osawa, T; Tsuda, T; Uchida, K	1
Henriksen, EJ; Lailerd, N; Saengsirisuwan, V; Sloniger, JA; Toskulkao, C	1
Allison, DB; Baker, BA; Coffey, CS; Steiner, D	1
An, X; Li, F; Yang, J; Zhao, Y; Zhou, M	1
Boozer, CN; Herron, AJ	1
Hasegawa, N; Mochizuki, M	1
Aida, K; Fukumitsu, S; Kobori, M; Ozawa, S; Takahashi, Y; Ueno, N	1
Cokelaere, M; Daenens, P; Darras, VM; Decuypere, E; Flo, G; Kühn, ER; Van Boven, M; Vermaut, S	1
Anai, M; Arakawa, K; Asano, T; Ishirahara, T; Kikuchi, M; Nawano, M; Oku, A; Saito, A; Ueta, K; Umebayashi, I	1
Smirnova, MG	1

Reviews

9 review(s) available for glucose, (beta-d)-isomer and Obesity

Article	Year
Biomaterial investigations in dentistry, 2021, Volume: 8, Issue:1 Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes; Black or African American; Bleaching Agents; Body Mass Index; Brugada Syndrome; Carbon; China; Climate Models; Codon, Nonsense; Cohort Studies; Colitis; Colon; COVID-19; Cytokines; Dental Enamel; Dextran Sulfate; Disease Models, Animal; Disease Outbreaks; Dogs; Electrocardiography; Escherichia coli; Esophageal Neoplasms; Female; Follow-Up Studies; Forests; Georgia; Glucosides; Healthy Volunteers; Heart Ventricles; Hesperidin; HIV Infections; Humans; Humidity; Hydrogen Peroxide; Incidence; Influenza, Human; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Male; Melanocortins; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Middle Aged; Muscular Dystrophy, Duchenne; Naphthol AS D Esterase; Naphthols; Neoplasms; Nitrates; Nitrites; Nitrous Oxide; Obesity; Pandemics; Patient Outcome Assessment; Patient Satisfaction; Plants; Prednisolone; Prednisone; Pregnenediones; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Rats; Receptor, Melanocortin, Type 1; Retrospective Studies; Risk Factors; SARS-CoV-2; Seasons; Soil; Stroke Volume; T-Lymphocytes; Telemedicine; Temperature; Tetralogy of Fallot; Tooth Bleaching; Tooth Bleaching Agents; Trees; Urea; White People	2021
Pharmacological effects of polydatin in the treatment of metabolic diseases: A review. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Jul-20, Volume: 102 Topics: AMP-Activated Protein Kinases; Atherosclerosis; Diabetes Mellitus; Glucosides; Gout; Humans; Non-alcoholic Fatty Liver Disease; Obesity; Phosphatidylinositol 3-Kinases; Quality of Life; Stilbenes	2022
Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2. JACC. Heart failure, 2018, Volume: 6, Issue:8 Topics: Aldosterone; Aminobutyrates; Angiotensin Receptor Antagonists; Benzhydryl Compounds; Biphenyl Compounds; Drug Combinations; Drug Therapy, Combination; Glucosides; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Neprilysin; Obesity; Plasma Volume; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Tetrazoles; Valsartan	2018
Type 2 diabetes mellitus and Invokana: an FDA approved drug. Current diabetes reviews, 2013, Volume: 9, Issue:6 Topics: Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Drug Approval; Female; Glucosides; Humans; Hypoglycemic Agents; India; Life Style; Male; Obesity; Thiophenes; United States; United States Food and Drug Administration	2013
[Type 2 diabetes mellitus and obesity: should we treat the obesity or the diabetes?]. Medicina clinica, 2013, Volume: 141 Suppl 2 Topics: Bariatric Surgery; Benzhydryl Compounds; Causality; Comorbidity; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Disease Management; Evidence-Based Medicine; Exercise Therapy; Glucagon-Like Peptide 1; Glucosides; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Obesity; Practice Guidelines as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss	2013
Obesity in 2015: Advances in managing obesity. Nature reviews. Endocrinology, 2016, Volume: 12, Issue:2 Topics: Bariatric Surgery; Benzhydryl Compounds; Caloric Restriction; Diabetes Mellitus, Type 2; Disease Management; Exercise Therapy; Feeding Behavior; Glucosides; Humans; Hypoglycemic Agents; Liraglutide; Obesity	2016
The cardiovascular phenotype: impact on choice of glucose- lowering therapy. JPMA. The Journal of the Pakistan Medical Association, 2016, Volume: 66, Issue:4 Topics: Acarbose; Benzhydryl Compounds; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Glucosides; Heart Rate; Humans; Hypoglycemic Agents; Metformin; Obesity; Phenotype	2016
Potential of rooibos, its major C-glucosyl flavonoids, and Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid in prevention of metabolic syndrome. Critical reviews in food science and nutrition, 2018, Jan-22, Volume: 58, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspalathus; Beverages; Diabetes Mellitus, Type 2; Dietary Supplements; Ethnopharmacology; Flavonoids; Glucosides; Humans; Isomerism; Medicine, African Traditional; Metabolic Syndrome; Obesity; Phenylpropionates; Plant Extracts; Plant Leaves; Plant Stems; South Africa; Teas, Herbal	2018
[Study of physiological and toxic effects of a sweetening agent stevioside (review of the literature)]. Voprosy pitaniia, 2001, Volume: 70, Issue:4 Topics: Animals; Carcinogenicity Tests; Diterpenes; Diterpenes, Kaurane; Female; Fetus; Glucosides; Humans; Male; Mutagenicity Tests; Obesity; Pregnancy; Rats; Rats, Wistar; Sweetening Agents; Terpenes; Time Factors	2001

Trials

26 trial(s) available for glucose, (beta-d)-isomer and Obesity

Article	Year
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial. Scientific reports, 2021, 09-24, Volume: 11, Issue:1 Topics: Adult; Body Mass Index; Catechin; Female; Glucosides; Hesperidin; Humans; Male; Middle Aged; Obesity; Placebos; Tea	2021
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial. Diabetes & metabolism, 2022, Volume: 48, Issue:2 Topics: Adiponectin; Adiposity; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Obesity	2022
Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes. The Journal of clinical endocrinology and metabolism, 2022, 05-17, Volume: 107, Issue:6 Topics: Benzhydryl Compounds; Blood Glucose; Brain; Cues; Diabetes Mellitus, Type 2; Double-Blind Method; Exenatide; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Obesity; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss	2022
The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial. Diabetes, obesity & metabolism, 2022, Volume: 24, Issue:8 Topics: Adult; Aged; Appetite; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Ghrelin; Glucagon-Like Peptide 1; Glucose; Glucosides; Humans; Hypoglycemic Agents; Middle Aged; Obesity; Overweight; Peptide YY; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss	2022
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial. Diabetes, obesity & metabolism, 2022, Volume: 24, Issue:8 Topics: Benzhydryl Compounds; Blood Glucose; Brain; Diabetes Mellitus, Type 2; Double-Blind Method; Exenatide; Glucose; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Obesity; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss	2022
Efficacy of Dapagliflozin Combined with Lifestyle Intervention in Obesity Control. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Aged; Benzhydryl Compounds; Body Mass Index; Glucosides; Humans; Life Style; Lipids; Middle Aged; Obesity; Waist Circumference	2022
Dapagliflozin Suppresses Hepcidin And Increases Erythropoiesis. The Journal of clinical endocrinology and metabolism, 2020, 04-01, Volume: 105, Issue:4 Topics: Anti-Infective Agents; Benzhydryl Compounds; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Erythropoiesis; Female; Follow-Up Studies; Glucosides; Glycated Hemoglobin; Hepcidins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Male; Middle Aged; Obesity; Prognosis; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors	2020
Effects of Dapagliflozin on Epicardial Fat Thickness in Patients with Type 2 Diabetes and Obesity. Obesity (Silver Spring, Md.), 2020, Volume: 28, Issue:6 Topics: Adipose Tissue; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Sodium-Glucose Transporter 2 Inhibitors	2020
Effects of Empagliflozin Treatment on Glycerol-Derived Hepatic Gluconeogenesis in Adults with Obesity: A Randomized Clinical Trial. Obesity (Silver Spring, Md.), 2020, Volume: 28, Issue:7 Topics: Adipose Tissue; Adult; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gluconeogenesis; Glucosides; Glycerol; Humans; Intra-Abdominal Fat; Liver; Male; Middle Aged; Obesity; Placebos; Weight Loss	2020
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial. Diabetologia, 2021, Volume: 64, Issue:1 Topics: Adult; Aged; Benzhydryl Compounds; Blood Glucose; Body Mass Index; Denmark; Exercise; Glucosides; Glycated Hemoglobin; Glycemic Control; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Obesity; Overweight; Prediabetic State; Treatment Outcome	2021
Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism, 2021, 09-27, Volume: 106, Issue:10 Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Drug Therapy, Combination; Exenatide; Female; Glucose Tolerance Test; Glucosides; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Obesity; Phentermine; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Topiramate; Treatment Outcome; Weight Loss; Young Adult	2021
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial. European heart journal, 2022, 08-14, Volume: 43, Issue:31 Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Humans; Obesity; Overweight; Sodium-Glucose Transporter 2 Inhibitors	2022
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:9 Topics: Adiposity; Anti-Obesity Agents; Benzhydryl Compounds; Body Mass Index; Cardiovascular Diseases; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Exenatide; Female; Follow-Up Studies; Ghrelin; Glucosides; Humans; Hypoglycemic Agents; Male; Membrane Transport Modulators; Middle Aged; Obesity; Peptides; Prediabetic State; Proof of Concept Study; Risk Factors; Sodium-Glucose Transport Proteins; Sweden; Venoms; Weight Loss	2017
Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial). BMJ open, 2017, 06-06, Volume: 7, Issue:5 Topics: Adult; Aged; Benzhydryl Compounds; Body Composition; Body Weight; Cardiovascular Diseases; Denmark; Double-Blind Method; Exercise; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Prediabetic State; Research Design; Risk Factors	2017
DECLARE-TIMI 58: Participants' baseline characteristics. Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:5 Topics: Aged; Benzhydryl Compounds; Body Mass Index; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glucosides; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Multicenter Studies as Topic; Obesity; Prevalence; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors	2018
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics. Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:8 Topics: Benzhydryl Compounds; Body Mass Index; Cardiorespiratory Fitness; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Drug Interactions; Female; Glucosides; Heart; Heart Failure; Humans; Male; Middle Aged; Obesity; Oxygen Consumption; Pilot Projects; Respiratory System; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume	2018
The effectiveness of dapagliflozin for sleep-disordered breathing among Japanese patients with obesity and type 2 diabetes mellitus. Endocrine journal, 2018, Sep-27, Volume: 65, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Asian People; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Japan; Male; Middle Aged; Obesity; Sleep Apnea Syndromes; Treatment Outcome; Young Adult	2018
Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study. Clinical endocrinology, 2019, Volume: 90, Issue:6 Topics: Adolescent; Adult; Anthropometry; Benzhydryl Compounds; Body Composition; Cardiovascular Diseases; Drug Administration Schedule; Female; Glucosides; Hormones; Humans; Life Style; Metformin; Middle Aged; Obesity; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult	2019
Canagliflozin: effects in overweight and obese subjects without diabetes mellitus. Obesity (Silver Spring, Md.), 2014, Volume: 22, Issue:4 Topics: Adult; Anti-Obesity Agents; Blood Pressure; Body Mass Index; Body Weight; Canagliflozin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucose; Glucosides; Humans; Male; Middle Aged; Obesity; Overweight; Sodium-Glucose Transport Proteins; Thiophenes; Treatment Outcome	2014
Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes. Diabetes care, 2014, Volume: 37, Issue:7 Topics: Aged; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Obesity; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Weight Loss	2014
Dietary supplementation with purified citrus limonin glucoside does not alter ex vivo functions of circulating T lymphocytes or monocytes in overweight/obese human adults. Nutrition research (New York, N.Y.), 2016, Volume: 36, Issue:1 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Beverages; Biomarkers; Body Mass Index; Cell Proliferation; Cells, Cultured; Citrus; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Fruit; Glucosides; Hepatitis; Humans; Limonins; Male; Metabolic Syndrome; Middle Aged; Monocytes; Obesity; Overweight; T-Lymphocytes	2016
Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial. Nutrition journal, 2016, Jan-19, Volume: 15 Topics: Abdominal Fat; Adiposity; Adult; Aged; Anti-Obesity Agents; Body Mass Index; Caffeine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucosides; Hesperidin; Humans; Male; Middle Aged; Obesity; Sensitivity and Specificity; Subcutaneous Fat; Surveys and Questionnaires; Triglycerides; Walking; Young Adult	2016
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus. Diabetes & vascular disease research, 2016, Volume: 13, Issue:2 Topics: Adiposity; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Weight Loss	2016
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:1 Topics: Adipose Tissue; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Composition; Body Weight; Double-Blind Method; Drug Therapy, Combination; Exenatide; Female; Glucose Intolerance; Glucosides; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Obesity; Peptides; Prediabetic State; Treatment Outcome; Venoms; Weight Loss	2017
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study. Journal of clinical pharmacology, 2010, Volume: 50, Issue:6 Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Drug Monitoring; Female; Glucosides; Glycosuria; Half-Life; Humans; Insulin; Male; Middle Aged; Obesity; Overweight; Prodrugs; Water-Electrolyte Balance	2010
A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2004, Volume: 28, Issue:11 Topics: Adult; Anti-Obesity Agents; Benzyl Alcohols; Body Mass Index; Caffeine; Cola; Double-Blind Method; Drug Combinations; Ephedra sinica; Ephedrine; Female; Glucosides; Humans; Logistic Models; Male; Middle Aged; Obesity; Phytotherapy; Plants, Medicinal; Salix; Statistics, Nonparametric; Time Factors; Weight Loss	2004

Other Studies

110 other study(ies) available for glucose, (beta-d)-isomer and Obesity

Article	Year
Effects of high-fat diet on somatic growth, metabolic parameters and function of peritoneal macrophages of young rats submitted to a maternal low-protein diet. The British journal of nutrition, 2017, Volume: 117, Issue:6 Topics: Animals; Diet, High-Fat; Diet, Protein-Restricted; Dietary Fats; Energy Intake; Female; Interferon-gamma; Lactation; Lipopolysaccharides; Macrophages, Peritoneal; Male; Malnutrition; Maternal Nutritional Physiological Phenomena; Nitric Oxide; Obesity; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats, Wistar; Weaning; Weight Gain; Zymosan	2017
Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. Journal of leukocyte biology, 2010, Volume: 87, Issue:1 Topics: Acute Disease; Animals; Ascitic Fluid; Chemokines, CXC; Dietary Fats; Female; Gene Expression Regulation; Inflammation; Interleukin-17; Interleukin-6; Intra-Abdominal Fat; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neutrophils; Obesity; Peritonitis; T-Lymphocyte Subsets; Thinness; Zymosan	2010
Editorial: acute inflammation in obesity: IL-17A in the middle of the battle. Journal of leukocyte biology, 2010, Volume: 87, Issue:1 Topics: Acute Disease; Adipose Tissue; Animals; CD4-Positive T-Lymphocytes; Diet; Female; Humans; Immunity, Innate; Inflammation; Interleukin-17; Leptin; Mice; Mice, Obese; Neutrophils; Obesity; Peritonitis; Zymosan	2010
Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Obesity (Silver Spring, Md.), 2007, Volume: 15, Issue:12 Topics: Adipogenesis; Adipose Tissue; Animals; Cell Movement; Chemokine CCL2; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Macrophages; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Obesity; Tissue Engineering; Zymosan	2007
Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice. Endocrinology, 2008, Volume: 149, Issue:8 Topics: Adipokines; Adiponectin; Animals; Female; Leptin; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Neutrophil Infiltration; Obesity; Peritonitis; Resistin; Zymosan	2008
Sodium glucose cotransporter 2 inhibitor dapagliflozin depressed adiposity and ameliorated hepatic steatosis in high-fat diet induced obese mice. Adipocyte, 2021, Volume: 10, Issue:1 Topics: Adiposity; Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucosides; Insulin Resistance; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Sodium-Glucose Transporter 2 Inhibitors	2021
Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights. European heart journal, 2022, 08-14, Volume: 43, Issue:31 Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Humans; Obesity; Sodium-Glucose Transporter 2	2022
Anthocyanins from Molecules (Basel, Switzerland), 2021, Oct-12, Volume: 26, Issue:20 Topics: Anthocyanins; Diabetes Mellitus, Type 2; Elaeocarpaceae; Fatty Liver; Glucosides; Hep G2 Cells; Hepatocytes; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Liver; Muscle Fibers, Skeletal; Muscle, Skeletal; Obesity; Olanzapine; Plant Extracts; Polyphenols	2021
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia. International journal of molecular sciences, 2021, Oct-26, Volume: 22, Issue:21 Topics: Animals; Benzhydryl Compounds; Cytochrome P-450 Enzyme System; Disease Models, Animal; Disease Progression; Glucosides; Hyperglycemia; Hyperlipoproteinemia Type IV; Inflammation Mediators; Insulin Resistance; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Prediabetic State; Rats; Rats, Mutant Strains; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors	2021
Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways. BioMed research international, 2021, Volume: 2021 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Angiogenesis Inhibitors; Animals; Biological Products; Disease Models, Animal; Diterpenes, Kaurane; Drug Compounding; Drug Synergism; Female; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipid Metabolism; Lipogenesis; Lipolysis; Mice; Mice, Inbred ICR; Obesity; Oleanolic Acid; Phytotherapy; RNA, Messenger; Saponins; Signal Transduction; Stevia; Tea	2021
Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling. Acta pharmacologica Sinica, 2022, Volume: 43, Issue:10 Topics: Animals; Benzhydryl Compounds; Cardiomyopathies; Glucosides; Inflammation; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Obesity; Palmitic Acid; Rats; Sodium-Glucose Transporter 2 Inhibitors; Transcription Factor AP-1	2022
Anti-adipogenic activity of maackiain and ononin is mediated via inhibition of PPARγ in human adipocytes. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 149 Topics: Adipocytes; Adipogenesis; Adiponectin; Anti-Obesity Agents; Glucosides; Humans; Isoflavones; Molecular Docking Simulation; Obesity; Phosphatidylinositol 3-Kinases; PPAR gamma; Pterocarpans; Sirtuin 1	2022
Dapagliflozin partially restores reproductive function in MC4R KO obese female mice. The Journal of endocrinology, 2022, 06-17, Volume: 254, Issue:2 Topics: Animals; Benzhydryl Compounds; Female; Glucosides; Growth Hormone; Human Growth Hormone; Humans; Hyperphagia; Luteinizing Hormone; Mice; Mice, Knockout; Obesity; Receptor, Melanocortin, Type 4	2022
Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice. International journal of molecular sciences, 2022, May-18, Volume: 23, Issue:10 Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Benzhydryl Compounds; Diabetes Mellitus; Glucose; Glucosides; Humans; Male; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Sodium-Glucose Transporter 2 Inhibitors	2022
Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1-Adiponectin Axis. Frontiers in endocrinology, 2022, Volume: 13 Topics: Adiponectin; Animals; Benzhydryl Compounds; Glucosides; Heme Oxygenase-1; Inflammasomes; Kidney; Membrane Proteins; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity	2022
Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin. Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:16 Topics: Adipose Tissue; Benzhydryl Compounds; Endothelial Cells; Female; Glucosides; Heart Failure; Humans; Neutrophils; Obesity; Phenotype; Stroke Volume	2022
A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice. Biochemical and biophysical research communications, 2022, 09-17, Volume: 621 Topics: Animals; Benzhydryl Compounds; Biliverdine; Glucosides; Metabolomics; Mice; Mice, Obese; Obesity	2022
Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model. International journal of molecular sciences, 2022, Sep-20, Volume: 23, Issue:19 Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Drinking Water; Glucose; Glucosides; Heart Failure; Lipids; Muscle, Skeletal; Obesity; Rats; Saponins; Sodium; Stroke Volume; Ventricular Function, Left	2022
Potential for Improvement of Gut Microbiota Deterioration Caused by a High-fat, High-sucrose Diet through Administration of Acylated Steryl-β-glycosides. Journal of oleo science, 2023, Volume: 72, Issue:12 Topics: Animals; Diet, High-Fat; Gastrointestinal Microbiome; Glucosides; Glycosides; Mice; Obesity; Sucrose	2023
Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice. Oncology reports, 2019, Volume: 42, Issue:6 Topics: Animals; Azoxymethane; Benzhydryl Compounds; Blood Glucose; Carcinogenesis; Cell Proliferation; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Mice, Obese; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Tumor Necrosis Factor-alpha	2019
Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model. Scientific reports, 2019, Oct-30, Volume: 9, Issue:1 Topics: Animals; Benzhydryl Compounds; Cell Differentiation; Cytokines; Diet, High-Fat; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Glucagon-Like Peptides; Glucosides; Immunoglobulin Fc Fragments; Mice; Obesity; Recombinant Fusion Proteins; Respiratory Hypersensitivity; RNA, Messenger; Th1 Cells; Th17 Cells	2019
Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet. BMJ open diabetes research & care, 2019, Volume: 7, Issue:1 Topics: Adipose Tissue, Brown; Animals; Benzhydryl Compounds; Diet, High-Fat; Fatty Liver; Glucosides; Insulin Resistance; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Obesity; Sodium-Glucose Transporter 2 Inhibitors; Weight Gain	2019
Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats. Clinical science (London, England : 1979), 2019, 12-12, Volume: 133, Issue:23 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diet, High-Fat; Endoplasmic Reticulum Stress; Gluconeogenesis; Glucosides; Glycosuria; Insulin Resistance; Liver; Male; Metformin; Obesity; Pancreas; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors	2019
Butyrate attenuated fat gain through gut microbiota modulation in db/db mice following dapagliflozin treatment. Scientific reports, 2019, 12-30, Volume: 9, Issue:1 Topics: Adipose Tissue; Animals; Benzhydryl Compounds; Butyric Acid; Disease Models, Animal; Gastrointestinal Microbiome; Glucose; Glucosides; Liver; Mice; Obesity; Sodium-Glucose Transporter 2 Inhibitors; Weight Gain	2019
Dapagliflozin restores insulin and growth hormone secretion in obese mice. The Journal of endocrinology, 2020, Volume: 245, Issue:1 Topics: Animals; Benzhydryl Compounds; Body Composition; Diabetes Mellitus, Type 2; Energy Metabolism; Gene Expression; Glucosides; Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin Secretion; Mice, Inbred C57BL; Mice, Knockout; Obesity; Sodium-Glucose Transporter 2 Inhibitors	2020
Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat. Cardiovascular diabetology, 2020, 02-18, Volume: 19, Issue:1 Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; Cellular Senescence; Disease Models, Animal; Endothelium, Vascular; Glucosides; Metabolic Syndrome; Obesity; Rats, Zucker; Sodium-Glucose Transporter 2 Inhibitors; Systole; Ventricular Function, Left; Ventricular Remodeling	2020
Dapagliflozin attenuates renal gluconeogenic enzyme expression in obese rats. The Journal of endocrinology, 2020, Volume: 245, Issue:2 Topics: Animals; Benzhydryl Compounds; Diet, High-Fat; Gluconeogenesis; Glucose-6-Phosphatase; Glucosides; Hypoglycemic Agents; Insulin-Like Growth Factor Binding Proteins; Intracellular Signaling Peptides and Proteins; Kidney; Male; Metformin; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar	2020
Molecules (Basel, Switzerland), 2020, Mar-11, Volume: 25, Issue:6 Topics: Amino Acids; Animals; Carbohydrate Metabolism; Choline; Diet, High-Fat; Diterpenes, Kaurane; Energy Metabolism; Glucosides; Hyperlipidemias; Lipid Metabolism; Magnetic Resonance Spectroscopy; Mesocricetus; Metabolomics; Obesity; Phenylacetates; Rubus	2020
Comparison of the effect of dapagliflozin on contrast to standard therapy of the patients with type 2 diabetes mellitus and concomitant obesity, their effect on laboratory and anthropometric parameters. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2020, Volume: 73, Issue:3 Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Obesity; Treatment Outcome	2020
The insulin-sensitising properties of the ellagitannin geraniin and its metabolites from International journal of food sciences and nutrition, 2020, Volume: 71, Issue:8 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Biological Transport; Cell Differentiation; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Glucosides; Hydrolyzable Tannins; Hyperglycemia; Insulin; Lipolysis; Mice; Obesity; Plant Extracts; Sapindaceae	2020
Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches. PloS one, 2020, Volume: 15, Issue:4 Topics: Animals; Anti-Obesity Agents; Carbohydrate Metabolism; Catechin; Cholestenones; Drugs, Chinese Herbal; Enzyme Assays; Flavanones; Glucosides; Humans; Molecular Docking Simulation; Obesity; Pancreatic alpha-Amylases; Swine; Weight Loss	2020
Glomerular hyperfiltration with hyperglycemia in the spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model. Physiological research, 2021, 03-17, Volume: 70, Issue:1 Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Glucosides; Hyperglycemia; Male; Obesity; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors	2021
Fournier's gangrene with dapagliflozin in a rural hospital: a case report. BMJ case reports, 2021, Feb-01, Volume: 14, Issue:2 Topics: Abscess; Accidental Falls; Aged; Anti-Bacterial Agents; Benzhydryl Compounds; Debridement; Diabetes Mellitus, Type 2; Drainage; Female; Fournier Gangrene; Glucosides; Hospitals, Rural; Humans; Hypoglycemic Agents; Insulin; Linagliptin; Obesity; Perineum; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds	2021
Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats. Journal of cellular physiology, 2021, Volume: 236, Issue:9 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Benzhydryl Compounds; Diet, High-Fat; Endoplasmic Reticulum Stress; Gene Expression Regulation; Glucose Tolerance Test; Glucosides; Inflammation; Kidney; Magnetic Resonance Imaging; Male; Malondialdehyde; Obesity; Oxidative Stress; Pancreas; Rats, Wistar; Signal Transduction; TOR Serine-Threonine Kinases; Vildagliptin	2021
Glucosyl Hesperidin Has an Anti-diabetic Effect in High-Fat Diet-Induced Obese Mice. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:3 Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Chemokine CCL2; Coculture Techniques; Diet, High-Fat; Disease Models, Animal; Glucosides; Hesperidin; Hyperglycemia; Hypoglycemic Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; RAW 264.7 Cells	2021
Syringin: A Phenylpropanoid Glycoside Compound in Molecules (Basel, Switzerland), 2021, Mar-11, Volume: 26, Issue:6 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cirsium; Glucosides; Lipid Metabolism; Mice; Obesity; Phenylpropionates; Phosphorylation; Plant Extracts; Plant Roots; PPAR gamma; Sterol Regulatory Element Binding Protein 1	2021
The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 140 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cellular Senescence; Diabetes Mellitus, Experimental; Diet, Western; Disease Models, Animal; Disease Progression; Glucosides; Hepatocytes; Insulin; Liver; Liver Neoplasms; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Obesity; Receptor, Melanocortin, Type 4; Sodium-Glucose Transporter 2 Inhibitors	2021
Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/streptozotocin-induced diabetes mellitus. Mitochondrion, 2021, Volume: 59 Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; DNA, Mitochondrial; Dynamins; Gene Dosage; Glucosides; GTP Phosphohydrolases; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Obesity; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Random Allocation; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin	2021
Nodakenin represses obesity and its complications via the inhibition of the VLDLR signalling pathway in vivo and in vitro. Cell proliferation, 2021, Volume: 54, Issue:8 Topics: 3T3-L1 Cells; Adipogenesis; Animals; Cell Differentiation; Cholesterol; Coumarins; Diet, High-Fat; Glucosides; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Obesity; Receptors, LDL; RNA Interference; RNA, Small Interfering; Signal Transduction; Weight Gain	2021
The sodium-glucose co-transporter 2 inhibitor dapagliflozin improves prognosis in systolic heart failure independent of the obesity paradox. European journal of heart failure, 2021, Volume: 23, Issue:10 Topics: Benzhydryl Compounds; Glucose; Glucosides; Heart Failure; Heart Failure, Systolic; Humans; Obesity; Prognosis; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Symporters	2021
Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes. BMC pharmacology & toxicology, 2017, 04-10, Volume: 18, Issue:1 Topics: Adult; Antihypertensive Agents; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypertension; Male; Middle Aged; Obesity; Plasma Volume; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2017
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. EBioMedicine, 2017, Volume: 20 Topics: Adipose Tissue; Adiposity; Animals; Benzhydryl Compounds; Biomarkers; Body Weight; Diet, High-Fat; Energy Metabolism; Fatty Acids; Fatty Liver; Glucose; Glucosides; Hypoglycemic Agents; Inflammation; Insulin Resistance; Macrophage Activation; Macrophages; Male; Mice; Muscle, Skeletal; Obesity; Oxidation-Reduction; Sodium-Glucose Transporter 2 Inhibitors	2017
Corn silk maysin ameliorates obesity in vitro and in vivo via suppression of lipogenesis, differentiation, and function of adipocytes. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 93 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Line; Cholesterol, LDL; Diet, High-Fat; Flavonoids; Glucosides; Lipogenesis; Mice; Mice, Inbred C57BL; Obesity; PPAR gamma; Triglycerides; Weight Gain; Zea mays	2017
Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor. Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:13 Topics: Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Young Adult	2017
Cyanidin-3-glucoside increases whole body energy metabolism by upregulating brown adipose tissue mitochondrial function. Molecular nutrition & food research, 2017, Volume: 61, Issue:11 Topics: Adipogenesis; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anthocyanins; Behavior, Animal; Dietary Supplements; Energy Intake; Energy Metabolism; Gene Expression Regulation; Glucosides; Liver; Locomotion; Male; Mice, Mutant Strains; Microscopy, Electron, Transmission; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Thermotolerance; Uncoupling Protein 1; Up-Regulation; Whole Body Imaging	2017
Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trials. Diabetes research and clinical practice, 2017, Volume: 131 Topics: Adult; Aged; Asian People; Benzhydryl Compounds; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Risk Factors; Treatment Outcome; Young Adult	2017
Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:14 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucosides; Humans; Intra-Abdominal Fat; Lipids; Liver; Magnetic Resonance Spectroscopy; Male; Obesity; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Tomography, X-Ray Computed	2017
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicology and applied pharmacology, 2017, 10-15, Volume: 333 Topics: Adamantane; Animals; Anti-Inflammatory Agents; Apoptosis; Benzhydryl Compounds; Brain; Cognition Disorders; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Glucosides; Insulin; Insulin Resistance; Long-Term Potentiation; Male; Malondialdehyde; Maze Learning; Membrane Potential, Mitochondrial; Memory; Mitochondria; Neuroprotective Agents; Nitriles; Obesity; Oxidative Stress; Pyrrolidines; Rats, Wistar; Reactive Oxygen Species; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Vildagliptin	2017
Antidiabetic and antiobesity effects of SGLT2 inhibitor ipragliflozin in type 2 diabetic mice fed sugar solution. European journal of pharmacology, 2018, Jan-05, Volume: 818 Topics: Adipose Tissue; Animal Feed; Animals; Body Weight; Diabetes Mellitus, Type 2; Glucosides; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Obesity; Sodium-Glucose Transporter 2 Inhibitors; Solutions; Sugars; Thiophenes	2018
Secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway. European journal of pharmacology, 2018, Feb-05, Volume: 820 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Butylene Glycols; Cell Survival; Diet, High-Fat; Glucosides; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Obesity; Signal Transduction	2018
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. International journal of molecular sciences, 2018, Jan-03, Volume: 19, Issue:1 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diet, Western; Glucosides; Inflammation; Insulin Resistance; Kidney Diseases; Kidney Glomerulus; Lipids; Liver; Liver Cirrhosis; Liver Diseases; Male; Mice, Inbred C57BL; Mice, Obese; Obesity; Oxidative Stress; Sodium-Glucose Transporter 2 Inhibitors; Weight Gain	2018
A new flavone glucoside together with known ellagitannins and flavones with anti-diabetic and anti-obesity activities from the flowers of pomegranate (Punica granatum). Natural product research, 2019, Volume: 33, Issue:2 Topics: alpha-Amylases; alpha-Glucosidases; Diabetes Mellitus; Flavones; Flowers; Glucosides; Hydrolyzable Tannins; Lipase; Lythraceae; Obesity; Plant Extracts; Structure-Activity Relationship	2019
Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:6 Pt A Topics: Animals; Benzhydryl Compounds; Diet, High-Fat; Disease Models, Animal; Glucosides; Humans; Insulin; Insulin Resistance; Kidney; Kidney Diseases; Male; Metformin; Obesity; Organic Anion Transporters, Sodium-Independent; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Sodium-Glucose Transporter 2	2018
Protective Effect of Ipragliflozin on Pancreatic Islet Cells in Obese Type 2 Diabetic db/db Mice. Biological & pharmaceutical bulletin, 2018, Volume: 41, Issue:5 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Fatty Acids; Glucosides; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Islets of Langerhans; Lipid Metabolism; Male; Mice; Mice, Obese; Obesity; Oxidative Stress; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triglycerides	2018
Madeira moneywort ( Natural product research, 2019, Volume: 33, Issue:22 Topics: alpha-Amylases; Antioxidants; Diabetes Mellitus, Type 2; Glucosidases; Glucosides; Lipase; Obesity; Oxidative Stress; Pharmaceutical Preparations; Phenols; Phytochemicals; Plant Extracts	2019
Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 103 Topics: Animals; Anthocyanins; Buthionine Sulfoximine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glucose; Glucosides; Glutathione; Inflammation; Kidney; Lipid Metabolism; Male; Mice, Inbred C57BL; Obesity; Protective Agents	2018
Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:2 Topics: Animals; Benzhydryl Compounds; Blood Pressure; Carbon-13 Magnetic Resonance Spectroscopy; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glucose; Glucosides; Heart; Ketones; Male; Myocardium; Obesity; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Weight Gain	2019
Journal of textile science & engineering, 2018, Volume: 8, Issue:2 Topics: Adult; Anabolic Agents; Androgens; Animals; Anthraquinones; Birth Weight; Body Mass Index; Carbon Isotopes; Cardiac Output; Case-Control Studies; Chromatography, High Pressure Liquid; Doping in Sports; Drugs, Chinese Herbal; Echocardiography; Emodin; Estranes; Exercise; Female; Gas Chromatography-Mass Spectrometry; Glucosides; Glycolysis; Hemodynamics; Hemoglobins; Herb-Drug Interactions; Humans; Hypothermia, Induced; Lactic Acid; Linear Models; Male; Monoterpenes; Muscle, Skeletal; Myoglobin; Nandrolone; Obesity; Oxygen Consumption; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnant Women; Prospective Studies; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Steroids; Substance Abuse Detection; Sulfates; Tandem Mass Spectrometry; Testosterone	2018
Long-Term Treatment with Empagliflozin Attenuates Renal Damage in Obese Zucker Rat. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2020, Volume: 128, Issue:8 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Administration Schedule; Glucosides; Kidney; Maintenance Chemotherapy; Male; Obesity; Rats; Rats, Zucker; Time Factors	2020
Influence of long term administration of tofogliflozin on chronic inflammation of visceral adipose tissue in mice with obesity induced by a high-fat diet. PloS one, 2019, Volume: 14, Issue:1 Topics: Albuminuria; Animals; Benzhydryl Compounds; Cellular Senescence; Diet, High-Fat; Drug Administration Schedule; Glucose Tolerance Test; Glucosides; Inflammation; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Obesity; Osteopontin; T-Lymphocytes; Tumor Necrosis Factor-alpha	2019
Polyphenols of Myrica faya inhibit key enzymes linked to type II diabetes and obesity and formation of advanced glycation end-products (in vitro): Potential role in the prevention of diabetic complications. Food research international (Ottawa, Ont.), 2019, Volume: 116 Topics: Aldehyde Reductase; alpha-Amylases; alpha-Glucosidases; Anthocyanins; Anti-Obesity Agents; Antioxidants; Azores; Diabetes Complications; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Flavonoids; Glucosides; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Lipase; Myrica; Obesity; Phytochemicals; Plant Extracts; Polyphenols; Portugal; Serum Albumin, Bovine	2019
RNA-seq analysis of diet-driven obesity and anti-obesity effects of quercetin glucoside or epigallocatechin gallate in Drosophila adults. European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:2 Topics: Animals; Anti-Obesity Agents; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Glucosides; Humans; Lipid Metabolism; Male; Metabolomics; Obesity; Oxidative Stress; Quercetin; RNA-Seq; RNA, Messenger; Species Specificity	2019
Rubrofusarin-6-β-gentiobioside inhibits lipid accumulation and weight gain by regulating AMPK/mTOR signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 62 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; Body Weight; Chromones; Diet, High-Fat; Glucosides; Humans; Lipid Metabolism; Male; Mesenchymal Stem Cells; Mice; Mice, Obese; Obesity; TOR Serine-Threonine Kinases; Weight Gain	2019
Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice. Cardiovascular diabetology, 2019, 06-24, Volume: 18, Issue:1 Topics: Adipocytes; Adipogenesis; Adipose Tissue; Adiposity; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fibrosis; Glucosides; Inflammation Mediators; Insulin Resistance; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Obesity; Paracrine Communication; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Vascular Remodeling; Vascular System Injuries	2019
Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity. Cardiovascular diabetology, 2019, 07-01, Volume: 18, Issue:1 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Canagliflozin; Diet, High-Fat; Disease Models, Animal; Glucose Transporter Type 4; Glucosides; Insulin Resistance; Isolated Heart Preparation; Male; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Myocytes, Cardiac; Obesity; Phlorhizin; Signal Transduction; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2019
Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice. European journal of pharmacology, 2013, Sep-05, Volume: 715, Issue:1-3 Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Fatty Liver; Glucose Tolerance Test; Glucosides; Glycosuria; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Obesity; Oxidative Stress; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2013
Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity. Nutrition research (New York, N.Y.), 2013, Volume: 33, Issue:6 Topics: Adipose Tissue, White; Animals; Citrus; Diet, High-Fat; Disaccharides; Dopamine; Glucosides; Hypothalamus; Kaolin; Male; Monoamine Oxidase; Norepinephrine; Obesity; Phenols; Phytotherapy; Plant Extracts; Plant Roots; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Rhodiola; Synephrine; Weight Loss	2013
Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid, an α-hydroxy acid from rooibos (Aspalathus linearis) with hypoglycemic activity. Molecular nutrition & food research, 2013, Volume: 57, Issue:12 Topics: Animals; Aspalathus; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Muscle, Skeletal; Obesity; Phenylpropionates; Rats; Rats, Wistar	2013
Effects of paeoniflorin on tumor necrosis factor-α-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes. Fitoterapia, 2013, Volume: 91 Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Anilides; Animals; Benzoates; Bridged-Ring Compounds; Chemokine CCL2; Drugs, Chinese Herbal; Gene Expression; Glucose; Glucosides; Inflammation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; Mice; Monoterpenes; Obesity; Paeonia; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; Tumor Necrosis Factor-alpha	2013
Salicortin-derivatives from Salix pseudo-lasiogyne twigs inhibit adipogenesis in 3T3-L1 cells via modulation of C/EBPα and SREBP1c dependent pathway. Molecules (Basel, Switzerland), 2013, Aug-30, Volume: 18, Issue:9 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; CCAAT-Enhancer-Binding Proteins; Drug Evaluation, Preclinical; Gene Expression; Glucosides; Inhibitory Concentration 50; Methanol; Mice; Obesity; Plant Extracts; Plant Stems; Salix; Solid Phase Extraction; Solvents; Sterol Regulatory Element Binding Protein 1	2013
SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats. European journal of pharmacology, 2014, Mar-15, Volume: 727 Topics: Adiposity; Animals; Anti-Obesity Agents; Biomarkers; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Fatty Acids; Glucosides; Glycosuria; Hypoglycemic Agents; Lipid Metabolism; Obesity; Oxidation-Reduction; Rats; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Time Factors; Up-Regulation; Weight Loss	2014
Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity. American journal of physiology. Endocrinology and metabolism, 2014, Jun-01, Volume: 306, Issue:11 Topics: Animals; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Eating; Glucagon; Glucokinase; Glucose; Glucose Clamp Technique; Glucosides; Hyperglycemia; Hyperinsulinism; Immunohistochemistry; Liver; Male; Obesity; Organ Size; Oxygen Consumption; Rats; Rats, Zucker; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2014
[Cyanidin-3-glucoside attenuates body weight gain, serum lipid concentrations and insulin resistance in high-fat diet-induced obese rats]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2014, Volume: 16, Issue:5 Topics: Animals; Anthocyanins; Blood Glucose; Diet, High-Fat; Glucosides; Insulin Resistance; Lipids; Male; Obesity; Rats; Rats, Sprague-Dawley; Weight Gain	2014
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension. American journal of physiology. Renal physiology, 2014, Aug-01, Volume: 307, Issue:3 Topics: Albuminuria; Animals; Benzhydryl Compounds; Blood Glucose; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Female; Glucosides; Hypertension; Hypertrophy; Hypoglycemic Agents; Kidney; Mice; Mice, Obese; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2014
Phillyrin, a natural lignan, attenuates tumor necrosis factor α-mediated insulin resistance and lipolytic acceleration in 3T3-L1 adipocytes. Planta medica, 2014, Volume: 80, Issue:11 Topics: 3T3-L1 Cells; Animals; Anti-Inflammatory Agents; Cell Survival; Glucose; Glucosides; I-kappa B Kinase; Insulin Resistance; Lignans; Lipolysis; Mice; Obesity; Tumor Necrosis Factor-alpha	2014
Phenylpropenoic acid glucoside augments pancreatic beta cell mass in high-fat diet-fed mice and protects beta cells from ER stress-induced apoptosis. Molecular nutrition & food research, 2014, Volume: 58, Issue:10 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Size; Cells, Cultured; Crosses, Genetic; Diabetes Mellitus, Type 2; Diet, High-Fat; Endoplasmic Reticulum Stress; Fructose; Glucosides; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Lipotropic Agents; Male; Mice, Transgenic; Obesity; Phenylpropionates; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; RNA Interference; Up-Regulation	2014
Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice. Diabetes, 2015, Volume: 64, Issue:1 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Therapy, Combination; Glucose; Glucose Clamp Technique; Glucosides; Glycated Hemoglobin; Hyperglycemia; Hypoglycemic Agents; Metformin; Mice, Knockout; Mice, Obese; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2015
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice. Cardiovascular diabetology, 2014, Oct-26, Volume: 13 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiovascular Diseases; Cognition Disorders; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Hypoglycemic Agents; Male; Mice, Inbred C57BL; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2014
A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice. Phytotherapy research : PTR, 2015, Volume: 29, Issue:2 Topics: Adipogenesis; Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Caffeine; Diet, High-Fat; Fatty Acid Synthases; Glucosides; Hesperidin; Lipids; Lipogenesis; Liver; Male; Mice; Mice, Obese; Obesity; Sterol Regulatory Element Binding Protein 1	2015
Stevia-derived compounds attenuate the toxic effects of ectopic lipid accumulation in the liver of obese mice: a transcriptomic and metabolomic study. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2015, Volume: 77 Topics: Amino Acids; Animals; Bile Acids and Salts; Disease Models, Animal; Diterpenes, Kaurane; Fatty Liver; Glucose; Glucosides; Glutathione; Insulin Resistance; Lipid Metabolism; Liver; Male; Metabolomics; Mice; Mice, Obese; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Plant Preparations; Stevia; Transcriptome	2015
Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:7 Topics: Animals; Blood Glucose; Body Weight; Diet, High-Fat; Glucosides; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Monoterpenes; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Protective Agents; Transcriptome	2015
[Weight also counts for patients]. MMW Fortschritte der Medizin, 2015, Apr-02, Volume: 157, Issue:6 Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Obesity; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss	2015
Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment. Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:2 Topics: Adult; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Glucosides; Humans; Hypoglycemic Agents; Insulin; Kidney Tubules, Proximal; Male; Medication Therapy Management; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome	2016
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. PloS one, 2016, Volume: 11, Issue:1 Topics: Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hypoglycemic Agents; Insulin Resistance; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome	2016
A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2016, Volume: 39, Issue:6 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Circadian Rhythm; Glucose Tolerance Test; Glucosides; Homeostasis; Hypertension; Hypoglycemic Agents; Insulin Resistance; Obesity; Rats; Rats, Inbred OLETF; Sodium Chloride, Dietary; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2016
Possible effects of Phillyrea latifolia on weight loss in rats fed a high-energy diet. Pharmaceutical biology, 2016, Volume: 54, Issue:10 Topics: Animals; Anti-Obesity Agents; Biomarkers; Blood Glucose; Chlorogenic Acid; Diet, High-Fat; Disease Models, Animal; Energy Intake; Glucosides; Hypoglycemic Agents; Intestine, Small; Lipids; Liver; Luteolin; Male; Obesity; Oleaceae; Phytotherapy; Plant Extracts; Plant Leaves; Plants, Medicinal; Rats, Wistar; Time Factors; Weight Loss	2016
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. PloS one, 2016, Volume: 11, Issue:3 Topics: Adipose Tissue; Adult; Animals; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Evaluation, Preclinical; Energy Intake; Epididymis; Glucose; Glucosides; Humans; Hyperphagia; Hypoglycemic Agents; Insulin Resistance; Leptin; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Weight Loss	2016
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats. Journal of gastroenterology, 2016, Volume: 51, Issue:12 Topics: Animals; Body Weight; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucosides; Hepatic Stellate Cells; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Cirrhosis, Experimental; Male; Obesity; Organ Size; Rats, Inbred OLETF; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2016
Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy. Endocrine journal, 2016, Jun-30, Volume: 63, Issue:6 Topics: Adult; Aged; Body Composition; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Intra-Abdominal Fat; Japan; Male; Middle Aged; Obesity; Thiophenes; Young Adult	2016
Salidroside improves glucose homeostasis in obese mice by repressing inflammation in white adipose tissues and improving leptin sensitivity in hypothalamus. Scientific reports, 2016, 05-05, Volume: 6 Topics: Adipose Tissue, White; Animals; Body Weight; Eating; Epididymis; Glucose-6-Phosphatase; Glucosides; Hyperglycemia; Hypothalamus; Inflammation; Leptin; Liver; Male; Mice; Mice, Obese; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenols; Triglycerides	2016
Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice. PloS one, 2016, Volume: 11, Issue:6 Topics: Animals; Body Weight; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Experimental; Diet, Carbohydrate-Restricted; Energy Intake; Fatty Acid Synthases; Forkhead Box Protein O1; Gluconeogenesis; Glucose Tolerance Test; Glucosides; Glycogen; Hyperglycemia; Insulin Resistance; Kidney; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Obesity; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triglycerides; Up-Regulation	2016
Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals. Diabetes & vascular disease research, 2016, Volume: 13, Issue:6 Topics: Acetylglucosaminidase; Albuminuria; Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cytoprotection; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glucosides; Hypoglycemic Agents; Kidney; Male; Mice, Inbred C57BL; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2016
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 359, Issue:1 Topics: Animals; Benzhydryl Compounds; Blood Glucose; Body Weight; Diet; Fasting; Glucose Tolerance Test; Glucosides; Inflammasomes; Kidney; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Myocardium; Obesity	2016
Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s. Obesity (Silver Spring, Md.), 2016, Volume: 24, Issue:9 Topics: Anti-Obesity Agents; Benzhydryl Compounds; Databases, Factual; Drug Prescriptions; Glucosides; Humans; Hypoglycemic Agents; Obesity; Phentermine; Practice Patterns, Physicians'; Retrospective Studies; United States; Weight Loss	2016
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice. European journal of pharmacology, 2009, Sep-15, Volume: 618, Issue:1-3 Topics: Administration, Oral; Animals; Benzhydryl Compounds; Drug Administration Schedule; Female; Glucose; Glucosides; Hyperinsulinism; Hypoglycemic Agents; Mice; Mice, Inbred Strains; Obesity; Time Factors	2009
Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. International journal of obesity (2005), 2010, Volume: 34, Issue:3 Topics: Adiponectin; Animals; Antioxidants; Atherosclerosis; Blood Glucose; Body Weight; Diterpenes, Kaurane; Glucosides; Insulin; Insulin Resistance; Mice; Mice, Obese; Obesity; Oxidative Stress; Signal Transduction; Sweetening Agents; Triglycerides	2010
Blood orange juice inhibits fat accumulation in mice. International journal of obesity (2005), 2010, Volume: 34, Issue:3 Topics: Adipose Tissue; Animals; Anthocyanins; Beverages; Body Weight; Citrus sinensis; Dietary Fats; Glucosides; Male; Mice; Mice, Inbred C57BL; Obesity	2010
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats. Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:11 Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Hyperglycemia; Islets of Langerhans; Obesity; Pancreas; Rats; Rats, Zucker; Sodium-Glucose Transporter 2 Inhibitors	2010
Cyanidin-3-O-β-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity. Journal of the science of food and agriculture, 2011, Volume: 91, Issue:6 Topics: AMP-Activated Protein Kinases; Animals; Anthocyanins; Cells, Cultured; Dietary Supplements; Female; Functional Food; Gene Expression Regulation, Enzymologic; Glucosides; Hypertriglyceridemia; Intra-Abdominal Fat; Lipoprotein Lipase; Liver; Mice; Muscle, Skeletal; Obesity; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; RNA, Messenger; Triglycerides	2011
The 2',4',6'-trihydroxyacetophenone isolated from Myrcia multiflora has antiobesity and mixed hypolipidemic effects with the reduction of lipid intestinal absorption. Planta medica, 2011, Volume: 77, Issue:14 Topics: Acetophenones; Animals; Anti-Obesity Agents; Cholesterol; Diet, High-Fat; Glucosides; Hypolipidemic Agents; Intestinal Absorption; Lactones; Lipase; Lipids; Lovastatin; Male; Mice; Myrica; Obesity; Orlistat; Pancreas; Plant Extracts; Rats; Rats, Wistar; Triglycerides; Weight Gain	2011
Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:4 Topics: Adipokines; Adipose Tissue, White; Animals; Anthocyanins; Chemokine CCL2; Diet, High-Fat; Dietary Fats; Fatty Liver; Forkhead Box Protein O1; Forkhead Transcription Factors; Glucosides; Hypoglycemic Agents; Insulin Resistance; Interleukin-6; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Signal Transduction; Triglycerides; Tumor Necrosis Factor-alpha	2012
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats. Obesity (Silver Spring, Md.), 2012, Volume: 20, Issue:8 Topics: 3-Hydroxybutyric Acid; Animals; Anti-Obesity Agents; Benzhydryl Compounds; Blood Glucose; Caloric Restriction; Diet; Dose-Response Relationship, Drug; Drinking; Energy Intake; Glucosides; Hyperphagia; Insulin; Male; Obesity; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Respiration; Sodium-Glucose Transport Proteins; Treatment Outcome; Weight Loss	2012
Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. The Journal of nutrition, 2003, Volume: 133, Issue:7 Topics: Adipose Tissue; Animals; Anthocyanins; Base Sequence; Body Weight; CCAAT-Enhancer-Binding Proteins; Diet; DNA Primers; DNA-Binding Proteins; Energy Intake; Glucosides; Hyperglycemia; Insulin Resistance; Lipids; Liver; Male; Mice; Mice, Inbred BALB C; Obesity; Organ Size; Sterol Regulatory Element Binding Protein 1; Transcription Factors	2003
Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle. Metabolism: clinical and experimental, 2004, Volume: 53, Issue:1 Topics: Animals; Biological Transport; Blood Glucose; Deoxyglucose; Diterpenes; Diterpenes, Kaurane; Fatty Acids, Nonesterified; Female; Glucose; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin; Insulin Resistance; Muscle, Skeletal; Obesity; Rats; Rats, Zucker	2004
[Effect of phillyrin on the anti-obesity in nutritive obesity mice]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2005, Volume: 28, Issue:2 Topics: Animals; Anti-Obesity Agents; Cholesterol; Drugs, Chinese Herbal; Forsythia; Glucosides; Male; Mice; Mice, Inbred ICR; Obesity; Plant Leaves; Plants, Medicinal; Triglycerides	2005
Simmondsin for weight loss in rats. International journal of obesity (2005), 2006, Volume: 30, Issue:7 Topics: Acetonitriles; Animals; Appetite Depressants; Body Composition; Body Weight; Cyclohexanes; Dose-Response Relationship, Drug; Eating; Erythrocytes; Glucosides; Kidney; Leukocytes; Liver; Male; Obesity; Organ Size; Rats; Rats, Sprague-Dawley; Thinness; Weight Loss	2006
Acceleration of lipid degradation by sericoside of Terminalia sericea roots in Fully differentiated 3T3-L1 cells. Phytotherapy research : PTR, 2006, Volume: 20, Issue:11 Topics: 3T3-L1 Cells; Adipocytes; Animals; Cytosol; Dose-Response Relationship, Drug; Glucosides; Glycerol; Lipid Metabolism; Lipolysis; Mice; Obesity; Oleanolic Acid; Plant Roots; Terminalia; Time Factors; Triglycerides	2006
Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. The British journal of nutrition, 2008, Volume: 100, Issue:3 Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Butylene Glycols; Cholesterol; Dietary Fats; Flax; Glucosides; Insulin; Leptin; Lignans; Male; Mice; Mice, Inbred C57BL; Obesity; PPAR gamma; RNA, Messenger; Triglycerides	2008
Effects of simmondsin on food intake, growth, and metabolic variables in lean (+/?) and obese (fa/fa) Zucker rats. The British journal of nutrition, 1999, Volume: 81, Issue:2 Topics: Acetonitriles; Adipose Tissue; Animals; Appetite Depressants; Body Temperature Regulation; Body Weight; Cholesterol; Cyclohexanes; Eating; Glucosides; Growth; Leptin; Male; Obesity; Proteins; Rats; Rats, Zucker; Time Factors	1999
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. American journal of physiology. Endocrinology and metabolism, 2000, Volume: 278, Issue:3 Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; Carbonates; Diabetes Mellitus; Glucokinase; Glucose Transporter Type 4; Glucose-6-Phosphatase; Glucosides; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Liver; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Rats; Rats, Zucker	2000